{"transactions":[{"id":4640439,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":242910,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640438,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":80,"price":551.49,"value":44119.2,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $551.37 to $551.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640437,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":160,"price":550.5929,"value":88094.864,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $550.31 to $551.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324523,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640436,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":502,"price":549.4687,"value":275833.2874,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $549.25 to $550.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324683,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640435,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":698,"price":548.4875,"value":382844.275,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $548.12 to $549.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325185,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640434,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":630,"price":547.4724,"value":344907.612,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $547.08 to $547.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325883,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640433,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":1452,"price":546.4596,"value":793459.3392,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $546.08 to $547.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326513,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640432,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":1507,"price":545.5221,"value":822101.8047,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $545.08 to $546.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":327965,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640431,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":1492,"price":544.5594,"value":812482.6248,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $544.08 to $545.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329472,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640430,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":2340,"price":543.4827,"value":1271749.518,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $543.06 to $544.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330964,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640429,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":639,"price":542.7569,"value":346821.6591,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $542.06 to $543.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333304,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4640428,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-14T20:31:07.000Z","date":"2026-10-13","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000163/primarydocument.xml","form_type":"4"}},{"id":4639508,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":252410,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639507,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":135,"price":554.4568,"value":74851.668,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $553.91 to $554.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639506,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":558,"price":552.9294,"value":308534.6052,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $552.59 to $553.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324578,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639505,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":1857,"price":551.9223,"value":1024919.7111,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $551.57 to $552.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325136,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639504,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":2628,"price":551.1025,"value":1448297.37,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $550.57 to $551.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326993,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639503,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":2565,"price":550.0292,"value":1410824.898,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $549.57 to $550.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329621,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639502,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":1329,"price":549.0136,"value":729639.0744,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $548.55 to $549.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332186,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639501,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":428,"price":548.1287,"value":234599.0836,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $547.54 to $548.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333515,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639500,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:31:26.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000162/primarydocument.xml","form_type":"4"}},{"id":4639491,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F22","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":261910,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639490,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":423,"price":550.7197,"value":232954.4331,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This transaction was executed in multiple trades at prices ranging from $550.46 to $551.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639489,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":1478,"price":549.9299,"value":812796.3922,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $549.46 to $550.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324866,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639488,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":2641,"price":548.9345,"value":1449736.0145,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $548.44 to $549.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326344,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639487,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":878,"price":548.0121,"value":481154.6238,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $547.37 to $548.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328985,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639486,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":240,"price":546.5979,"value":131183.496,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $546.36 to $546.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329863,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639485,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":545.899,"value":218359.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $545.20 to $546.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330103,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639484,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":544.544,"value":217817.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $544.20 to $545.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330503,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639483,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":240,"price":543.2133,"value":130371.192,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $542.57 to $543.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330903,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639482,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":40,"price":541.51,"value":21660.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331143,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639481,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":320,"price":540.74,"value":173036.8,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $540.47 to $541.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331183,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639480,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":200,"price":539.228,"value":107845.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $538.87 to $539.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331503,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639479,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":538.3252,"value":215330.08,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $537.83 to $538.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331703,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639478,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":360,"price":537.0462,"value":193336.632,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $536.72 to $537.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332103,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639477,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":536.09,"value":214436.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $535.64 to $536.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332463,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639476,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":640,"price":534.7975,"value":342270.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $534.40 to $535.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332863,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639475,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":320,"price":533.8007,"value":170816.224,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $533.19 to $534.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333503,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639474,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":120,"price":531.92,"value":63830.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333823,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4639473,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:30:34.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000161/primarydocument.xml","form_type":"4"}},{"id":4638725,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F22","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":271410,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638724,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":40,"price":541.23,"value":21649.2,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638723,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":424,"price":540.5072,"value":229175.0528,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This transaction was executed in multiple trades at prices ranging from $540.20 to $540.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of\nthe issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324483,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638722,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":1091,"price":539.5806,"value":588682.4346,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $539.09 to $540.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324907,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638721,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":605,"price":538.6004,"value":325853.242,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $538.08 to $539.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325998,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638720,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":1016,"price":537.5336,"value":546134.1376,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $537.01 to $537.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326603,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638719,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":824,"price":536.6074,"value":442164.4976,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $536.00 to $536.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of\nthe issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":327619,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638718,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":480,"price":535.4582,"value":257019.936,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $534.96 to $535.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328443,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638717,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":920,"price":534.2819,"value":491539.348,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $533.92 to $534.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328923,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638716,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":800,"price":533.361,"value":426688.8,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $532.81 to $533.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of\nthe issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329843,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638715,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":600,"price":532.0737,"value":319244.22,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $531.74 to $532.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330643,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638714,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":1061,"price":531.0725,"value":563467.9225,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $530.70 to $531.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331243,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638713,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":199,"price":530.1342,"value":105496.7058,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $529.66 to $530.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332304,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638712,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":200,"price":528.626,"value":105725.2,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $528.47 to $528.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of\nthe issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332503,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638711,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":273,"price":527.5745,"value":144027.8385,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $527.42 to $527.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332703,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638710,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":767,"price":526.6638,"value":403951.1346,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $526.12 to $527.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332976,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638709,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":200,"price":525.4958,"value":105099.16,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $525.02 to $525.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333743,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638708,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-09T20:31:15.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000160","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000160/primarydocument.xml","form_type":"4"}},{"id":4638087,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F21","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":280910,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638086,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":400,"price":556.4848,"value":222593.92,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $556.18 to $556.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638085,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":930,"price":555.7726,"value":516868.518,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $555.17 to $556.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324843,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638084,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":485,"price":554.5126,"value":268938.611,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $554.14 to $555.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325773,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638083,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":185,"price":553.7019,"value":102434.8515,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $553.11 to $553.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326258,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638082,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":440,"price":552.2949,"value":243009.756,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $551.77 to $552.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326443,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638081,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":486,"price":551.0942,"value":267831.7812,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $550.75 to $551.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326883,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638080,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":874,"price":550.1356,"value":480818.5144,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $549.73 to $550.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":327369,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638079,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":1173,"price":549.1301,"value":644129.6073,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $548.71 to $549.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328243,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638078,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":387,"price":548.177,"value":212144.499,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $547.70 to $548.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329416,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638077,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":629,"price":546.9442,"value":344027.9018,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $546.32 to $547.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":329803,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638076,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":493,"price":545.8505,"value":269104.2965,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $545.32 to $546.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330432,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638075,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":2098,"price":544.8212,"value":1143034.8776,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $544.25 to $545.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330925,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638074,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":744,"price":543.7592,"value":404556.8448,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $543.24 to $544.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333023,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638073,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":176,"price":542.7339,"value":95521.1664,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $542.21 to $543.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333767,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4638072,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:28:35.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000159/primarydocument.xml","form_type":"4"}},{"id":4637158,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F24","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":290410,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637157,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":80,"price":545.495,"value":43639.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"This transaction was executed in multiple trades at prices ranging from $545.48 to $545.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637156,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":842,"price":544.752,"value":458681.184,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"This transaction was executed in multiple trades at prices ranging from $544.48 to $545.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324523,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637155,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":558,"price":543.9937,"value":303548.4846,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This transaction was executed in multiple trades at prices ranging from $543.45 to $544.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325365,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637154,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":120,"price":542.4903,"value":65098.836,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $542.21 to $543.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325923,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637153,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":380,"price":541.5549,"value":205790.862,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $541.19 to $542.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326043,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637152,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":2054,"price":540.6783,"value":1110553.2282,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $540.16 to $541.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326423,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637151,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":1606,"price":539.6752,"value":866718.3712,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $539.14 to $540.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328477,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637150,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":1088,"price":538.6083,"value":586005.8304,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $538.12 to $539.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":330083,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637149,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":133,"price":537.5758,"value":71497.5814,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $537.10 to $538.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331171,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637148,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":323,"price":536.2515,"value":173209.2345,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $536.05 to $537.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331304,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637147,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":734,"price":535.7087,"value":393210.1858,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $535.005 to $536.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":331627,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637146,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":167,"price":534.3018,"value":89228.4006,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $533.99 to $534.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332361,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637145,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":215,"price":533.1439,"value":114625.9385,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $532.85 to $533.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332528,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637144,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":320,"price":531.9384,"value":170220.288,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $531.31 to $532.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":332743,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637143,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":240,"price":530.1333,"value":127231.992,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $529.71 to $530.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333063,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637142,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":360,"price":528.7197,"value":190339.092,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $528.39 to $529.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333303,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637141,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":280,"price":527.9029,"value":147812.812,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $527.36 to $528.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333663,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4637140,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-07T20:35:13.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":117.76,"value":1118720.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":333943,"source":{"system":"sec-edgar","filing":"0001106578-26-000158","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000158/primarydocument.xml","form_type":"4"}},{"id":4636182,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Stock Option","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries."}],"balance_after":299910,"derivative":{"exercise_price":117.76,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636181,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":360,"price":546.6322,"value":196787.592,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $546.24 to $547.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324443,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636180,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":920,"price":545.6922,"value":502036.824,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $545.24 to $546.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":324803,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636179,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":1260,"price":544.5928,"value":686186.928,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $544.20 to $545.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":325723,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636178,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":783,"price":543.5419,"value":425593.3077,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $543.20 to $544.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":326983,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636177,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":918,"price":542.5566,"value":498066.9588,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $542.18 to $543.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":327766,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}},{"id":4636176,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":665,"kind":"person","name":"ROTHBLATT MARTINE A","position":1,"cik":"0001106578","reported_name":"ROTHBLATT MARTINE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairperson & CEO"}}],"security":"Common Stock","published_at":"2026-10-06T20:32:13.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":1239,"price":541.6628,"value":671120.2092,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $541.17 to $542.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."}],"balance_after":328684,"source":{"system":"sec-edgar","filing":"0001106578-26-000157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1106578/000110657826000157/primarydocument.xml","form_type":"4"}}],"next_cursor":"2026-10-06T20:32:13.000000Z,4636176"}